Government Relations News
The Association of National Advertisers (ANA) has urged the Federal Trade Commission (FTC) to reject a proposed change in the Guides Concerning the Use of Endorsements and Testimonials in Advertising.
The Health Subcommittee of the House Energy and Commerce Committee held a legislative hearing today on a number of discussion drafts of pending bills, including the drug safety bill originally introduced by Reps. Ed Markey (D-MA) and Henry Waxman (D-CA), which contains a number of provisions that would severely restrict DTC advertising for new drugs.
The Chairman of the House Energy and Commerce Subcommittee on Health, Congressman Frank Pallone, has released a discussion draft of the drug safety bill. That draft contains five new restrictions on prescription drug advertising to consumers.
The House Energy and Commerce Subcommittee on Health is expected to markup a drug safety bill on Wednesday, June 13, 2007. It is possible that there may be provisions to ban or restrict prescription drug advertising included in the Chairman
The Institute of Medicine issued a report yesterday calling on the federal government to take various actions to reduce tobacco use, including major restrictions on advertising.
Senator Tom Harkin (D-IA) has reintroduced his HeLP America Act (S. 1342), which contains a number of provisions that impact advertisers.
FCC Chairman Martin and Commissioners Tate and Copps have responded to House Telecommunications and the Internet Subcomittee Chairman Ed Markey's letter urging serious new restrictions on food marketing.
After weeks of negotiations, the Senate yesterday passed the drug safety bill, S.1082, without major new restrictions on direct-to-consumer prescription drug ads.
The Federal Communications Commission (FCC) last night released their long awaited report on "Violent Television Programming and Its Impact on Children."
We have learned that the Senate leadership is likely to bring up the drug safety bill (S.1082) as early as next Monday. This bill contains provisions that are an enormous threat to the advertising community.
Yesterday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a markup on S. 1082, the Food and Drug Administration Revitalization Act, which contains a two-year moratorum on advertising for prescription drugs and new government-mandated warnings for ads.
Two important developments on the children's advertising front.
The Senate HELP Committee plans to mark up S. 484, the Enhancing Drug Safety and Innovation Act, on Wednesday, April 18. The bill contains three provisions of concern to the advertising industry.
ANA is serving on a joint government/industry task force that will be meeting next Friday to discuss potential new initiatives. One of our goals is to develop a comprehensive inventory of the efforts already being made by individual marketers to address childhood obesity. Therefore, we need examples of programs or partnerships that your company has begun to address childhood obesity.
On March 23, 2007, the federal court in Utah denied the motion for preliminary injunction in this very important case dealing with a do-not-email registry enacted in 2004.
In his "State of the State" speech last week, Illinois Governor Rod Blagojevich proposed a new gross receipts tax (GRT) on all business activity in the state.
There have been several important developments on the state ad tax front.
The marketing community may be facing ad tax battles in the legislatures in Michigan and Iowa. We need your assistance to respond to these threats.
Last week, to mark National Consumer Protection Week, the House Energy and Commerce Committee introduced four major privacy bills. The bills deal with data security, spyware, pretexting, and social security number protection.
The first month of the new Congress has seen a flurry of legislative activity in the prescription drug advertising area.